Literature DB >> 26658994

microRNA and Chronic Lymphocytic Leukemia.

Dana Elena Giza1,2, George A Calin3,4.   

Abstract

Expression profiling of microRNAs identified important differences in microRNA expression between CLL samples and normal CD5+ B-cells. Researchers have first discussed the dual role of miRNAs working as tumor suppressors (inhibiting malignant potential) or as oncogenes (activating malignant potential) in CLL pathogenesis. Understanding the roles of miRNAs in leukemic cells brings information on a new layer of gene regulation and also provides new markers for improved diagnosis and prognosis, as well as novel therapeutic options for CLL patients. Herein we will focus on the roles of miRNAs in CLL, highlighting what is already known about their function, proposing a novel model of CLL predisposition and progression, and describing the challenges for the near future.

Entities:  

Keywords:  ATM mutation; CLL; IGHV; ZAP-70; miRNAs

Mesh:

Substances:

Year:  2015        PMID: 26658994     DOI: 10.1007/978-3-319-23730-5_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones.

Authors:  Giovanna Carrà; Cristina Panuzzo; Davide Torti; Guido Parvis; Sabrina Crivellaro; Ubaldo Familiari; Marco Volante; Deborah Morena; Marcello Francesco Lingua; Mara Brancaccio; Angelo Guerrasio; Pier Paolo Pandolfi; Giuseppe Saglio; Riccardo Taulli; Alessandro Morotti
Journal:  Oncotarget       Date:  2017-05-30

2.  MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.

Authors:  Yasuo Takashima; Atsushi Kawaguchi; Yasuo Iwadate; Hiroaki Hondoh; Junya Fukai; Koji Kajiwara; Azusa Hayano; Ryuya Yamanaka
Journal:  PLoS One       Date:  2019-01-07       Impact factor: 3.240

3.  miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma.

Authors:  Yasuo Takashima; Atsushi Kawaguchi; Yasuo Iwadate; Hiroaki Hondoh; Junya Fukai; Koji Kajiwara; Azusa Hayano; Ryuya Yamanaka
Journal:  PLoS One       Date:  2020-02-26       Impact factor: 3.240

4.  Coronavirus disease 2019 and mRNA vaccines: what's next - miRNA?

Authors:  Joon Kee Lee; Heon-Seok Han
Journal:  Clin Exp Pediatr       Date:  2022-03-28

5.  miRNA-331-3p Affects the Proliferation, Metastasis, and Invasion of Osteosarcoma through SOCS1/JAK2/STAT3.

Authors:  Dan Zu; Qi Dong; Sunfang Chen; Yongde Chen; Jun Yao; Yubin Zou; Jiawei Lin; Bin Fang; Bing Wu
Journal:  J Oncol       Date:  2022-09-26       Impact factor: 4.501

6.  MicroRNA-101 regulates T-cell acute lymphoblastic leukemia progression and chemotherapeutic sensitivity by targeting Notch1.

Authors:  Lu Qian; Wanggang Zhang; Bo Lei; Aili He; Lianhong Ye; Xingzhou Li; Xin Dong
Journal:  Oncol Rep       Date:  2016-09-21       Impact factor: 3.906

Review 7.  MicroRNAs in Vascular Eye Diseases.

Authors:  Chi-Hsiu Liu; Shuo Huang; William R Britton; Jing Chen
Journal:  Int J Mol Sci       Date:  2020-01-19       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.